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Objective: To describe protocol adaptations to the Fibromyalgia Integrative Training for Teens (FIT Teens) ran
domized controlled trial in response to the COVID-19 pandemic. The overarching aims of the FIT Teens multi-site
3-arm comparative effectiveness trial are to assess whether a specialized neuromuscular exercise training
intervention combined with cognitive-behavioral therapy (CBT) is superior to CBT alone or graded aerobic ex
ercise alone.
Design/methods: The trial was originally designed as an in-person, group-based treatment with assessments at
baseline, mid- and post-treatment, and four follow-up time points. The original study design and methodology
was maintained with specific modifications to screening, consenting, assessments, and group-based treatments to
be delivered in remote (telehealth) format in response to COVID-19 restrictions.
Results: Study enrollment was paused in March 2020 for five months to revise operations manuals, pilot remote
treatment sessions for accuracy and fidelity, complete programming of REDCap assent/consent and assessment
materials, train study staff for new procedures and obtain regulatory approvals. The trial was relaunched and has
been successfully implemented in remote format since July 2020. Trial metrics thus far demonstrate a consistent
rate of enrollment, strong attendance at remote treatment sessions, high retention rates and high treatment fi
delity after protocol adaptations were implemented.
Conclusions: Preliminary findings indicate that FIT Teens protocol adaptations from in-person to remote are
feasible and allowed for sustained enrollment, retention, and treatment fidelity comparable to the in-person
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format. Methodologic and statistical considerations resulting from the adaptations are discussed as well as im
plications for interpretation of results upon completion of the trial.

1. Introduction

in August 2020 as lockdown measures relaxed, but in-person research
visits remained restricted.
The purpose of the current report is to describe the modifications
made to the FIT Teens study protocol in response to the COVID-19
pandemic, along with the scientific principles and practical multi-site
study implementation issues that guided our decision-making. We first
describe all relevant adaptations to the trial which focused on main
taining scientific integrity of the study. Next, trial metrics (i.e., enroll
ment, randomization, retention, session attendance rates and safety) are
provided for the 22-month period following protocol changes. Finally,
the implications of trial modifications that will inform the interpretation
of study findings at trial completion are discussed.

Juvenile fibromyalgia (JFM) is a chronic and disabling musculo
skeletal pain condition for which there are limited therapeutic options
[1–5]. The Fibromyalgia Integrative Training (FIT Teens) trial is an
ongoing multi-site, 3-arm randomized controlled trial (RCT) to evaluate
whether
the
FIT
Teens
intervention,
which
combines
cognitive-behavioral therapy (CBT) with specialized neuromuscular
exercise training, is superior to CBT alone or graded aerobic exercise
(GAE) alone [6]. A description of the FIT Teens study protocol has been
previously published [7].
Trial enrollment began in January 2018. With the declaration of the
COVID-19 pandemic in March 2020, restrictions on in-person research
activities presented challenges for trial implementation. New enroll
ment was temporarily halted to focus on modifying study processes and
treatments for use in a remote (telehealth) format and obtaining sponsor
and regulatory approval for these changes. Active recruitment resumed

Fig. 1. Study Visit Flow Chart with Adaptations (in italics)
*Note: As in T1, all self-report measures are completed remotely via REDCap, while fitness assessments are conducted in-person.
2
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2. Design/methods

app in the original e-diary format.
Since resuming the trial in remote format, we have maintained a
consistent rate of enrollment - on average 6.5 participants per month
pre-pandemic versus 6.6 participants per month since August 2020.
Thus far, 724 total patients have been referred to the study, with 316
participants enrolled as of March 1, 2022 [of which 169 (58%) were
enrolled pre-pandemic], and 257 randomized to receive treatment (of
which 136 were randomized prior to March 2020) (Fig. 2).

2.1. Overview of original trial design
The FIT Teens trial aims to enroll 420 adolescents (ages 12–17) with
JFM who are randomly assigned to one of the three active interventions.
Each intervention arm involves group-based treatment sessions held
twice per week over eight weeks, originally designed to be completed inperson. The primary outcome is functional disability, with pain intensity
being the secondary outcome. Additional measures include patient
report of fatigue, coping efficacy, and mood, as well as objective mea
sures of physical fitness, strength, and functional biomechanics. We
hypothesized that those who receive the FIT Teens intervention will
demonstrate significantly greater reduction in functional disability and
pain at the 3-month assessment following treatment compared to the
CBT and GAE interventions. Follow-up assessments at 6-, 9- and 12months will assess maintenance of treatment gains (see Fig. 1).

2.4. Assessments
2.4.1. Patient-reported outcome measures
All measures were initially completed in-person via pencil and paper.
Following protocol adaptations, the majority of the study measures were
modified to be administered remotely via REDCap [11,12]. Measures
include the primary outcome measure, Functional Disability Inventory
(FDI; [9, 13]), secondary outcome measure Visual Analog Scale of Pain
Intensity (VAS; [14]), as well as four additional outcome measures (e.g.,
Tampa Scale of Kinesiophobia [15], Pain Catastrophizing Scale [16],
NIH PROMIS Short Form Measures [17,18], and Pain Coping Efficacy
[19]). Given the potential for safety concerns (e.g., suicidal ideation) on
the CDI-II [9], it was decided that participants must complete this
measure with trained research coordinators during synchronous video
or telephone appointments to facilitate immediate risk assessment and
implementation of safety protocols as needed.
To assess the pandemic’s impact on study participants, we added a
measure to assess perceived effects of the COVID-19 pandemic and
related restrictions on social, academic, and family functioning. This
measure is a 16-item subscale from the COVID-19 Adolescent Symptom
& Psychological Experience Questionnaire (CASPE). Response options
are on a 5-point rating scale, representing degrees of concern (“very
little or not at all” to “a great deal”) [20].
School format (e.g., regular school, online, homebound etc.) was
assessed as a supplementary indicator of daily functioning in the original
protocol. As online schooling became almost universal during the
COVID era, this variable had to be revised to record additional modes of
instruction and clarify the reason for any homebound/online instruction
(i.e., COVID-19 worries, pain-related problems, and personal prefer
ence). Subsequent analyses will likely need to account for this factor,
because academic functioning is a component of functional disability
and the pandemic impacted all students’ academic functioning.
Potential impact of mode of assessment. All questionnaires utilizing
REDCap were publicly available, such that adapting the self-report
questionnaires to electronic data capture was relatively straightfor
ward. The only copyrighted study measure is the CDI-II, which is indi
vidually administered by a trained research coordinator via telehealth.
To facilitate future investigation of the impact of mode of administration
on psychometric properties of outcome measures, we created a new
binary indicator variable in the database (i.e., 0 = paper-pencil, 1 =
online administration).

2.2. Participants/sample characteristics
Inclusion and exclusion criteria for study eligibility remain un
changed. Adolescents (ages 12–17 years) diagnosed with primary JFM
are eligible if they do not have comorbid rheumatic disease, untreated
psychiatric condition (e.g., major depression, bipolar disorder, psycho
ses, and substance abuse/misuse) or developmental delay that may
interfere with treatment. Psychiatric screening is performed using sub
scales of the validated Adolescent Symptom Inventory (ASI- Parent
Report; [8]) and the Children’s Depression Inventory – 2 (CDI - II; 9). If
the participant/parent endorses symptoms indicating a psychiatric
condition, additional assessment is performed, in consultation with the
site psychologist to determine if treatment is ongoing and symptoms are
well-controlled. If not, referrals for appropriate mental health care are
provided. Anxiety disorders are common comorbidities in JFM and as
long as they are not disabling enough to interfere with study partici
pation, are not exclusionary.
Adolescents have to meet American College of Rheumatology (ACR
2010) criteria for fibromyalgia [10], have at least moderate disability
(Functional Disability Inventory Score ≥13), and pain intensity rating
(in the past week) of ≥4/10 on a visual analog scale [7].
Potential impact on sample characteristics. Most study visits are now
conducted remotely, which may provide flexibility to some families who
were not otherwise able to participate due to distance and travel.
Therefore, it will be important to consider whether the change to remote
delivery resulted in systematic differences in demographic characteris
tics of participants enrolled pre-versus post-pandemic (e.g., geographic
location, distance from medical center).
2.3. Recruitment process, consent, and screening for eligibility
Participants are identified from new or existing patients with JFM
who present to pediatric rheumatology or pain clinics. Prior to the
pandemic, recruitment involved primarily face-to-face interactions be
tween research coordinators and patients/families in medical clinics.
Based on adapted recruitment processes, clinicians and/or other clinical
providers introduce the study to participants. Interested families can
also view a 3-min study overview video. With verbal permission,
research coordinators use remote means (i.e., overview video, phone
contact, and email) to provide study details and pre-screen for eligi
bility. Families who remain interested in participation are scheduled to
confirm eligibility and complete the formal assent/consent process. The
informed consent process was adapted to be conducted via video/phone
call using an electronic consent form programmed into REDCap [11,12]
and signed electronically, in accordance with institutional policies. After
consent (and child assent) are obtained, parent/caregiver and partici
pants receive email links to self-report assessment measures (REDCap).
In addition, they complete a 7-day electronic pain diary on a smartphone

2.4.2. Physical assessments
Physical assessments included functional biomechanics, fitness,
strength, and daily physical activity. During initial pandemic lock
downs, all physical assessments were suspended. As restrictions on inperson visits were relaxed by institutions, fitness assessments that
could be conducted following social distancing requirements were
resumed (i.e., 6-min walk test and Harvard step test). Physical assess
ments requiring proximity between assessors and participants for
marker placements and equipment adjustments, such as strength and
biomechanic assessments, were gradually reintroduced following
approval of safety protocols at each institution. Actigraphy measures of
daily physical activity were discontinued due to COVID-19 surface
transmission considerations and logistical challenges with device man
agement (shipping etc.). The majority of the sites resumed in-person
fitness assessments within 2 months of initiating the remote protocol.
3

S. Kashikar-Zuck et al.

Contemporary Clinical Trials Communications 30 (2022) 101039

Fig. 2. Monthly actual versus expected enrollment, and randomization.

Motion capture assessments requiring more stringent safety and sani
tation procedures resumed approximately 4 months later.. Regional
variation in COVID restrictions did not systematically affect ability to
perform assessments. However, staffing difficulties common during the
pandemic, did affect one site’s ability to resume fitness and motion
capture assessments.
Potential impact on trial aims. Because collection of physical assess
ments was more severely affected by pandemic restrictions, we expect
more missing data for these analyses. These missing data will not affect
the primary outcomes of the trial but may limit our proposed explor
atory analyses looking at the mediating role of fitness and biomechan
ical improvements in treatment outcomes. Therefore, we retain data
collection on these measures whenever possible due to their innovative
nature and the potential to inform future studies.

have been few instances of participant noncompliance with safety
measures.
The remote treatment protocols require that all materials be deliv
ered to participants prior to the first session. A single, contactless pickup visit is coordinated to deliver equipment and handouts to partici
pants. Specifically, the CBT treatment group receives a basket of relax
ation materials (i.e., CDs/software, squishy balls) to facilitate the use of
relaxation and distraction strategies at home. The FIT Teens treatment
group receives a BOSU® (BOth Sides Up) Balance Trainer Ball to facil
itate neuromuscular exercise training at home, while the GAE treatment
group receives an activity monitor and heart rate monitor to facilitate
implementation of the aerobic training program. Each participant also
receives a packet of printed treatment handouts specific to their group
assignment, including worksheets for coping skills practice and/or ex
ercise logs and pictures.
Thus far, feedback from participants and their families indicates high
levels of satisfaction with the convenience and accessibility of the
remote treatment sessions. Attendance rates for the remote format
average 14.87/16 sessions attended, which is comparable to 14.67/16
for in-person attendance prior to the pandemic. Of 41 families asked
about their preferences for treatment format, 100% of parents/care
givers expressed preference for a remote format going forward due to
lower cost and time of transportation and ease of family schedules.
Feedback from adolescents was mixed, with 16 indicating a preference
for the in-person format (to meet the other teens in person and get to
know them better) and 25 for the remote format. Based on overall family
preferences for remote sessions and due to continuing concerns about
virus transmission, we decided to continue treatment delivery in remote
format for the remainder of the trial.
Potential impact on intervention delivery. Prior research indicates that
in-person versus remote (telehealth) psychological interventions can
produce equivalent results [22–26]. Similarly, exercise-based ap
proaches can also be effectively delivered in telemedicine format com
parable to in-person delivery [27–29]. Nevertheless, changing mid-trial
from in-person to remote treatment delivery will allow us to assess
whether mode of delivery had a differential impact on outcomes and, if
so, we will control this in the final intent-to-treat analysis. We created
two additional indicator variables to track whether each session took
place pre- or post-pandemic, and the mode of treatment delivery for
each group.

2.4.3. Interventions
Modifications to the CBT and exercise treatment arms (i.e., FIT
Teens, GAE) from an in-person group-based protocol to remote format
were necessary to balance treatment fidelity with participant safety
during the pandemic. Treatment manuals were adapted so that all study
visits and intervention components could be conducted via secure,
synchronous video communication (i.e., Zoom or Microsoft® Teams
based on site preference) (for session-by-session treatment content [7].
To help participants randomized to the FIT Teens groups learn the
neuromuscular exercises in session, study exercise staff created a library
of videos to ensure treatment fidelity and consistency of delivery across
sites. The videos were designed to be easily integrated into the virtual
platforms and played as needed during remote sessions [21]. The CBT
components of the FIT Teens treatment and CBT alone protocols were
also adapted for remote delivery. Treatment educational materials and
handouts were digitized and/or made into editable documents for easy
screen sharing during virtual sessions.
Lastly, adapting the GAE treatment to remote delivery required us to
modify the circuit training approach. Instead of using gym equipment (i.
e., treadmill, elliptical, or stationary bike), the GAE protocol was
adapted to rely on floor-based aerobic exercises and heart rate monitors
to set the difficulty level.
Because of privacy and safety concerns when conducting sessions in
a home-based setting, additional precautions are implemented to ensure
safety and confidentiality. To encourage compliance with safety mea
sures, participants are reminded at the start of group sessions that they
must be in a private space, with a parent or caregiver present for the
entire session, and their video turned on. If any of these requirements is
not met, the participant is asked to leave the remote session and join
only when these criteria are met. Feedback from trainers indicates there

2.4.4. Interventionist training
At the beginning of the trial (in 2018), all study interventionists
participated in a 2-day training at the primary site facilitated by the lead
FIT-Teens psychology and exercise trainers. Given restricted travel
4
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during the pandemic, trainers had to complete retraining on the adapted
study protocols remotely. To accommodate this, all revised manuals and
study materials (e.g., handouts, presentation materials) were uploaded
to a file sharing program to allow trainers to review the adapted pro
tocols. Next, the lead site’s trainers completed a 2-h virtual training
session during which key adaptations to the manuals and remote study
protocols were reviewed. Specialized instruction for exercise and psy
chology trainers was delivered separately in smaller sub-groups for
trainers to further discuss how to deliver the CBT and exercise training
portions. Lead trainers reviewed safety considerations, new virtual
materials such as the trainer presentation guide and exercise videos, and
tips for clinical implementation in a remote delivery setting. The
training session was also recorded for future educational purposes
related to staffing changes.
Each site was provided with additional site-specific virtual trainings
on the revised treatment manuals with more detailed discussion focused
on patient safety. This included managing safety if a participant did not
have a parent/caregiver in the home during a session, facilitating oneon-one communication during groups, etc. Ongoing remote trainings
continue to be provided to help train new study staff on standard
operating procedures and treatment protocols. Monthly virtual trainer
meetings provide a forum for study updates and problem-solving; these
meetings were held both pre- and post-pandemic.

merged with the Medidata Rave® data. As a result, all research co
ordinators manually transfer information from the electronic case report
forms (CRFs) from the REDCap system into Medidata Rave®. Quality
control checks remain unchanged. The data-coordinating center con
ducts audits of electronic CRFs and Medidata Rave® data entry to pre
vent missingness and ensure accuracy of the data entered. For the
primary and secondary outcome variables, data entry has been main
tained at 99% accuracy.
2.4.9. Analytic plan
Our primary data analysis plan remains as originally proposed, with
slight modifications to account for changes in format of treatment de
livery. We will begin with an initial review of all relevant variables,
including those added after onset of the pandemic (e.g., COVID-19
impact questionnaire). Baseline group comparisons will be compared
for equivalence on functional disability and pain intensity across the
three intervention groups. In addition, we will explore any potential
shifts in demographic characteristics of the sample before and after the
onset of the pandemic and between group differences on the COVID-19
impact questionnaire for those enrolled after the onset of the pandemic.
Primary analyses will utilize a longitudinal Structural Equation
Modeling (SEM) approach as planned, where repeated longitudinal as
sessments (level 1) are nested within participants (level 2) who are
tested in cohorts of participants (level 3) within each of the six study
sites (level 4). The longitudinal SEM approach will determine if the FIT
Teens treatment is superior to GAE and CBT at reducing functional
disability, and whether group differences in functional disability scores
are maintained over time (6-, 9-, and 12-month follow-up). To assess the
impact that modifications to the treatment delivery have on study out
comes, we will test whether in-person versus remote mode of delivery
has a differential effect on functional disability and pain. Further, as an
exploratory analysis, the mode of treatment delivery indicator variable
will be used to create an independent group interaction term (e.g.,
format x GAE, format x CBT) to evaluate any differential impact of mode
of treatment on treatment allocation (CBT, FIT or GAE).

2.4.5. Treatment fidelity
Independent review of sessions to ensure fidelity of treatment de
livery has been part of the trial since it began. For in-person groups, sites
recorded sessions with tablets and uploaded video files to a protected
server. The same general process was followed with the transition to
remote groups, leveraging the recording features of each virtual plat
form and using existing fidelity rating forms. A preliminary assessment
suggests that high treatment fidelity has been maintained between the
in-person delivery of the treatment protocol (98.4%) and the remote
format (99.7%). Treatment fidelity data continue to be reported to the
Data Safety Monitoring Board (DSMB) at regular intervals.
2.4.6. Adverse event monitoring
Adverse events are regularly assessed during the treatment sessions
and assessment visits, documented, and reported to the DSMB and study
sponsors as appropriate, with no changes to pre-pandemic procedures. A
review of adverse events after the pandemic onset did not show any
remarkable changes in the frequency or nature of events, by body sys
tem, except for non-study related respiratory adverse events which
increased slightly due to the COVID-19 pandemic. Since the start of the
pandemic, we have had twenty-one adverse events due to a positive
COVID-19 diagnosis among participants. One participant had a severe
adverse event related to COVID-19 complications which required brief
hospitalization. Adverse events deemed to be “definitely” or “possibly’
study-related in the remote protocol remained similar to the in-person
format and included mild and temporary musculoskeletal symptoms,
which is expected given that 2 of the 3 interventions involve physical
exercise training.

3. Discussion
The FIT Teens trial is a multi-site comparative effectiveness RCT that
aims to establish whether a multi-component intervention (CBT +
neuromuscular exercise training) is superior to CBT or GAE in the
treatment of JFM. In the context of the ongoing opioid crisis that con
tinues to surge during the pandemic [30], the evaluation of safe and
effective non-addictive and non-pharmacologic approaches for chronic
pain disorders is even more critical to disrupt the often unremitting
course of pain and disability from adolescence to adulthood.
The FIT Teens trial was adapted in its third year as a result of the
COVID-19 pandemic and has been implemented with minimal inter
ruption. Implementing the adapted, remotely delivered treatment pro
tocols have been feasible as evidenced by sustained participant
enrollment, retention, and fidelity of treatment in a manner comparable
to in-person delivery. Notably, remote delivery of the adapted treatment
protocols has maintained participant safety and produced no untoward
effects on adverse events. With appropriate precautions we have found
that remote treatment can be administered safely in a comparable
manner to in-person treatment. Moreover, although some families
expressed a reluctance to participate in remote treatment due to “Zoom
fatigue,” enrollment and retention was comparable to when treatment
was in-person. Parents/caregivers expressed a preference for remote
treatment due to convenience. Feedback from the teens was more mixed,
with many favoring the in-person format for more direct socialization
with their peers. Preferences for in-person versus remote format did not
appear to be site/region specific and seemed to be more related to teen’s
personal preferences.
Even with considerable efforts to preserve the integrity of the trial
after the onset of the pandemic, we need to consider new factors

2.4.7. Data and safety monitoring
Due to the protocol modifications, the DSMB convened quarterly
rather than every six months to monitor the integrity of the trial and
participant safety during the transition to remote delivery. Since the trial
was successfully relaunched, the meetings have resumed a biannual
meeting schedule with monthly enrollment reports.
2.4.8. Data management and quality control
The main study database is housed within the data coordinating
center at the primary site and utilizes Medidata Rave® as the centralized
electronic database. As noted, all patient-reported outcome measures
were adapted to be completed via REDCap. A notable limitation arising
from this modification is that REDCap data exports are unable to be
5
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the context of the FIT Teens trial, no one declined or discontinued trial
participation due to lack of internet; however, on occasion internet
speed or bandwidth issues have hindered audio connectivity for par
ticipants. Based on feedback from trainers, audio issues were frequently
circumvented using the chat function and/or dialing into the virtual
session using a separate device. In addition, the ability to deliver the
treatment protocols in a remote format allowed us to capitalize on
expertise irrespective of geographical location. For instance, with the
remote format, psychology and exercise trainers from the primary site
were able to help provide coverage to ongoing groups at study sites
across the country.

introduced midway through the trial in the final interpretation of study
outcomes:1) the unprecedented scale and duration of the pandemic has
unknown psychosocial, health, and economic effects on research
broadly and our study population [31], specifically. This raises impor
tant questions about whether these environmental factors will influence
study outcomes. Fortunately, we are administering validated measures
of psychological distress and coping that will allow us to examine these
effects in a post-hoc fashion (including newly added measures of COVID
impact and disrupted schooling). Given reports of the mental health
impact of the pandemic on teens, we examined whether there was a
significant increase in baseline depressive symptoms in the FIT Teens
cohort from pre-pandemic to after the onset of the pandemic. Contrary
to what we expected, we found that depressive symptoms actually
reduced slightly after the onset of the pandemic [32] which may have
resulted from reduction in school and social expectations. This some
what attenuates our concern about marked changes in baseline
emotional functioning of the sample. A second factor for consideration
would be the differential impact of in-person versus remote treatment
delivery on study outcomes. Therefore, the mode of treatment delivery
will need to be examined separately or controlled for in the final intent
to treat analysis. Third, measurement invariance across modes of
administration (paper-pencil versus electronic) of patient-reported
outcomes is uncertain and will need to be evaluated.
From a process standpoint, successful implementation of the adapted
treatment protocol and study relaunch relied heavily on the coordinated
effort and investment of the study staff, including research coordinators,
interventionists, and investigators across all sites. A critical ingredient to
successful implementation was high quality communication, which was
accomplished through regularly scheduled virtual meetings to keep sites
and research staff at all levels engaged and allowed the trial to be
relaunched synchronously across all study sites. Real-time problemsolving and maintaining team morale was critical in the context of fur
loughs/absences due to illness or quarantine, remote work, training/
retraining staff remotely, and rapidly changing institutional (and statelevel) regulations for research activities.
Although the realities of the pandemic resulted in more complexity
than initially planned, unexpected innovations have emerged that may
inform future work. Specifically, remotely delivered group-based
treatment can provide pilot data on whether intervention efficacy is
equivalent between treatment modalities. These data may be used to
inform future trials aimed at optimizing dissemination. For instance, if
the FIT Teens treatment protocol is determined to be superior to CBT
and GAE, adapting the treatment protocol to increase ease of access will
be a useful next step. In response to parents’ preferences for a fully
remote intervention and some adolescents’ desire for more in-person
contact, it may be beneficial to offer either in-person or remote treat
ment and potentially a hybrid option, mixing in-person and remote
sessions to maximize social engagement.
Social distancing requirements during the pandemic necessitated
considerable reliance on technology by treatment providers that quickly
outpaced the literature and majority of evidence-based treatment in
terventions for chronic pain. This rapid push to integrate technology to
enhance delivery of evidence-based treatments for chronic pain may
overcome previous overreliance on traditional treatment modalities and
influence the next generation of treatment programs and selfmanagement tools. For example, as part of the adaptation of the pro
tocol to remote format, we created a library of videos for neuromuscular
training that can easily be shared with participants to view on their own
to support regular home practice.
Whereas many evidence-based treatments rely on in-person contact,
remote options have the potential to increase treatment access by
removing barriers of geographic proximity. Moreover, offering treat
ment remotely could have implications for addressing health care dis
parities, especially for those who live further away from medical centers
or from lower SES groups. We are cognizant that access to internet or
technology may be a barrier to participation for a subset of patients. In

4. Conclusion
This paper described modifications to the implementation of the FIT
Teens RCT that allowed the trial to resume enrollment, maintain
retention, and ensure participant safety in a manner consistent with trial
implementation prior to the pandemic. At the completion of the trial, it
is hoped that this transparency in reporting will allow clarity in the
interpretation of trial results and establish the foundation for dissemi
nation efforts if the study hypotheses are supported.
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